The CEOs of an Indiana-based community health center and a primary care association recently wrote an op-ed that called for [...] Read More »
Month: November 2023
GlaxoSmithKline owes refunds to 340B providers, according to a notice posted on the Health Resources and Services Administration’s Office of [...] Read More »


TIP: Proactively keep abreast of the evolving landscape of the Inflation Reduction Act and the associated Part B Inflation Rebate Guidance. Accurate tracking
A recent ruling by a federal district judge in South Carolina potentially could expand 340B-eligible prescriptions, say some provider advisers. [...] Read More »
Hospital advocates praised the recent Medicare final rule implementing a $9 billion lump sum payment to 340B hospitals but worried [...] Read More »
Pharmaceutical giant Eli Lilly this week announced it would reinstate tighter 340B contract pharmacy restrictions for all covered entity types. [...] Read More »
A federal district judge in Illinois has dismissed a Chicago hospital’s apparently successful lawsuit challenging its termination from the 340B [...] Read More »
A group of Senate Republicans recently urged federal regulators to withdraw a plan to change the definition of a drug’s [...] Read More »
An influential drug industry trade group recently urged a federal judge to rule on its suit against Louisiana’s 340B contract [...] Read More »
The Arkansas Insurance Department (AID) recently asked a federal district judge to dismiss Novo Nordisk’s lawsuit that challenges Arkansas’ state [...] Read More »